ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome - sprookjes - yvandenbroek - TriplyDB

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

http://www.wikidata.org/entity/Q24657877

about

The notch ligand JAGGED1 as a target for anti-tumor therapy Salinomycin as a drug for targeting human cancer stem cells Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells MUC1-C oncoprotein activates ERK→C/EBPβ signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling Double-negative feedback loop between reprogramming factor LIN28 and microRNA let-7 regulates aldehyde dehydrogenase 1-positive cancer stem cells CD133: to be or not to be, is this the real question?OCT4 Expression Enhances Features of Cancer Stem Cells in a Mouse Model of Breast Cancer ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome c-Jun induces mammary epithelial cellular invasion and breast cancer stem cell expansion.CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis ALDH1 expression correlates with favorable prognosis in ovarian cancers MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression Aldehyde dehydrogenase-expressing colon stem cells contribute to tumorigenesis in the transition from colitis to cancer Mammary Development and Breast Cancer: A Wnt Perspective Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy The hedgehog pathway in triple-negative breast cancer Diabetes mellitus and metformin in hepatocellular carcinoma Stem-like features of cancer cells on their way to metastasis Therapeutic Effectiveness of Anticancer Phytochemicals on Cancer Stem Cells Wnt Signaling in Cancer Stem Cell Biology Stem cell technology in breast cancer: current status and potential applications Cancer stem cells (CSCs), cervical CSCs and targeted therapies Application prospective of nanoprobes with MRI and FI dual-modality imaging on breast cancer stem cells in tumor Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells Immune targeting of cancer stem cells in gastrointestinal oncology Liver cancer stem cell markers: Progression and therapeutic implications Breast cancer stem-like cells: clinical implications and therapeutic strategies Multiple myeloma cancer stem cells A Role for Notch Signalling in Breast Cancer and Endocrine Resistance Cancer stem cells and immunoresistance: clinical implications and solutions Cancer Stem Cell Plasticity Drives Therapeutic Resistance Aldehyde dehydrogenase 1A1 in stem cells and cancer New Findings on Breast Cancer Stem Cells: A Review Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer

P2860

Q21129294-845B88D4-20EA-4C93-9043-635EA6461F76 Q21285139-2545B559-E737-4BA0-832B-FC88EFF355DB Q21562662-787ACF89-3420-4FE4-8F88-046D9864A20A Q24300043-DDE067BF-5A05-43EF-B909-D47B36DCB313 Q24329077-DD1D0F43-F076-422F-A58E-03747EF67CB7 Q24336566-3A71E28C-D399-4E3A-83A9-DEB149E279C4 Q24597245-893DABCF-6280-4E55-977D-7F17D11215CD Q24598592-FCABD76D-A13F-4B42-A9E5-B26A5EE943B7 Q24615405-C75E3DD4-498C-4C0F-99E0-16DEEC6FB522 Q24627533-26FBA063-AF84-4ECB-B411-87FDB0FE1259 Q24631043-4792E320-628D-472C-83E1-224B9BDBD3E6 Q24633165-C384F9DF-8736-49C3-B71A-2BBB63D42E9E Q24642170-7572D4D6-3F0B-4859-B925-791C30E45DF1 Q24645253-3AE82209-78C2-49A6-B4F9-C8C332EB657C Q24649718-CEC9B167-04BB-4B95-9811-F35538BCFAFD Q24651422-14FCF6D8-40FE-4EC4-8D40-F17191E5003D Q24657020-9E5FA1E9-AB4E-401B-A7E8-B77A827F1533 Q24657250-DE05EB9D-E04A-44C2-B2D8-D20296B99869 Q24657355-031816B8-2FC4-4325-9EA9-5933264EB126 Q26740086-C0E8072C-33EF-4BD5-8586-2F7D599BED06 Q26740207-55C9178F-F235-41E8-8493-CEF86442FF1F Q26740373-8386B575-F858-4ECD-B2FA-67E6EB0B94E7 Q26741205-B1C0C304-01B9-4E6B-AD2B-DB010BAF5706 Q26741641-58AA5F2A-3656-4D16-A424-B8616194AF65 Q26744724-03FCFFDD-792C-48B2-9725-15507DE2F1AA Q26746101-ED5EDC41-E87C-41C2-AB51-5F1019130033 Q26746223-6D80A683-A008-49E4-9B4A-793DDC41FFBB Q26747144-CAFD448B-8FB4-4E5D-B8C8-8F2A32B620DB Q26747389-74CC5821-52E4-4760-91EA-E2F4A13755F2 Q26748850-9AB77897-E19B-4D98-8A84-277896CC370A Q26749015-9D8E95F2-B16C-4443-A69E-CC8B3C9ADBA3 Q26751026-67F6D7FD-219B-4D1D-9A14-A376FBDA4D17 Q26752170-223E843A-0382-4C1C-8464-730FAB65CFB2 Q26752365-3960D68B-65C9-46D5-9312-B14FB68A6B8D Q26765912-9E386AD6-914B-4017-BD83-24D375F23534 Q26769757-3446C841-DA98-4419-85D0-8C1C7D3CE9FE Q26770274-F49446D9-57FE-4D10-9658-ECE31E9A5CF6 Q26771185-9BBDB623-EE68-4E4A-B763-B41AD524E429 Q26771894-F9249FB4-7FC4-4CF0-A6B0-9870B75D6258 Q26773907-9F222B95-1FAD-40E2-B12E-D56CCBBFC6D6

P2860

ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome

http://www.wikidata.org/entity/Q24657877

description

2007 nî lūn-bûn

@nan

2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

ALDH1 is a marker of normal an ...... ictor of poor clinical outcome

@ast

ALDH1 is a marker of normal an ...... ictor of poor clinical outcome

@en

ALDH1 is a marker of normal an ...... ictor of poor clinical outcome

@nl

type

label

ALDH1 is a marker of normal an ...... ictor of poor clinical outcome

@ast

ALDH1 is a marker of normal an ...... ictor of poor clinical outcome

@en

ALDH1 is a marker of normal an ...... ictor of poor clinical outcome

@nl

prefLabel

ALDH1 is a marker of normal an ...... ictor of poor clinical outcome

@ast

ALDH1 is a marker of normal an ...... ictor of poor clinical outcome

@en

ALDH1 is a marker of normal an ...... ictor of poor clinical outcome

@nl

P1433

Q24657877-2F90446A-03AC-457A-89F8-E41464A24B98

P1476

Q24657877-5142D661-298B-4052-A32B-7D8648EB470A

P2093

Q24657877-0840AAB4-AFD3-4196-8AFF-E7C487038D62

Q24657877-2EAF2F01-AEDE-4D8C-B173-5F7DFF208855

Q24657877-3256DE42-1E15-4005-A50E-9B5ACAD568AF

Q24657877-43EA5D45-B3E0-4AD5-91BD-4AF7959CC58C

Q24657877-4D751916-79BD-4D52-89F5-F3C6567BB885

Q24657877-66171CE3-AD6E-47C9-B692-D2CF1450DC1C

Q24657877-72385E38-60B0-4418-A364-BD857484C5E7

Q24657877-BA6646B9-A4E6-4CD0-BD95-276F80323D02

Q24657877-D7EA6084-5CE6-4216-83EC-5EAA37474C2B

Q24657877-D879D318-F63B-48E2-B9B9-2C5DAF658A92

P2860

Q24657877-01CDE728-B09D-4D36-81D6-CC718996495A

Q24657877-024A3C70-C70C-4B14-B7F3-CE399D65BBB1

Q24657877-095B8626-9295-447D-978C-8E9E6F742AD0

Q24657877-0977FD9C-5C77-4318-8F2F-44FDB9820BB1

Q24657877-17F7E07C-655E-4D5E-9F8F-61BCED7F25E6

Q24657877-22D01BF3-C15C-47FE-9E66-301663A8B638

Q24657877-236F4917-8EC5-4C9C-A50A-8AFD60DAC084

Q24657877-2A68A5AE-ABF9-4761-AC93-211E0C746D52

Q24657877-2B90A0E0-0BFA-4AFC-8B1A-0EB0BCBFBC81

Q24657877-2E82CACB-3351-4A93-9330-2B53A90BAA3C

P304

Q24657877-43C20EF8-14B8-449F-8365-CAD2051249DD

P31

Q24657877-59B1D2F4-74A0-4B06-8599-E7E08D9571B0

P3181

Q24657877-7A35A9ED-5A14-42CF-BE75-8D12AD40F161

P356

Q24657877-C88BDF16-3BE9-4380-86D2-344B67F676CC

P407

Q24657877-134C1FF2-980A-47A5-88CA-32781C9FB8EA

P433

Q24657877-448DB611-3377-47DC-963C-47960A0B4DF6

P478

Q24657877-DE4F537E-9279-48D9-A320-DE911B5891BE

P50

Q24657877-142F3117-A049-4889-BD1A-16A05BB3358A

Q24657877-610E2992-CCA8-4354-AE0C-D1448074C543

Q24657877-CB1EAD5B-75E5-477D-882C-AB5904679075

P577

Q24657877-2BAC1F47-A558-4E8E-B8B5-ECDC9992B893

P5875

Q24657877-473A3909-567D-4046-A742-91DA81AD2A38

P698

Q24657877-C1185E27-9C17-44FD-A082-508C95AE430B

P921

Q24657877-F96C5C9D-8EBA-48E9-8C57-088757E2728E

P932

Q24657877-574F7700-14BA-479E-9183-DA87E1433F8A

P3181

P356

J.STEM.2007.08.014

P1433

P1476

ALDH1 is a marker of normal an ...... ictor of poor clinical outcome

@en

P2093

Anne Schott

http://www.w3.org/2001/XMLSchema#string

Celina G Kleer

http://www.w3.org/2001/XMLSchema#string

Dan Hayes

http://www.w3.org/2001/XMLSchema#string

Daniel Birnbaum

http://www.w3.org/2001/XMLSchema#string

Florence Monville

http://www.w3.org/2001/XMLSchema#string

Gabriela Dontu

http://www.w3.org/2001/XMLSchema#string

Julie Dutcher

http://www.w3.org/2001/XMLSchema#string

Marty Brown

http://www.w3.org/2001/XMLSchema#string

Max S Wicha

http://www.w3.org/2001/XMLSchema#string

Min Hee Hur

http://www.w3.org/2001/XMLSchema#string

P2860

Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer

Characterization of clonogenic multiple myeloma cells

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells

Prospective identification of tumorigenic breast cancer cells

Identification and expansion of human colon-cancer-initiating cells

Gene expression profiling predicts clinical outcome of breast cancer

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

Stem cells, cancer, and cancer stem cells

Identification of human brain tumour initiating cells

P304

555-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

87775

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.STEM.2007.08.014

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Emmanuelle Charafe-Jauffret

Jocelyne Jacquemier

Christophe Ginestier

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5482024

http://www.w3.org/2001/XMLSchema#string

P698

18371393

http://www.w3.org/2001/XMLSchema#string

P921

P932

2423808

http://www.w3.org/2001/XMLSchema#string